Manic Fringe Antikörper
Kurzübersicht für Manic Fringe Antikörper (ABIN7183808)
Target
Alle Manic Fringe (MFNG) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Kreuzreaktivität
- Human
-
Aufreinigung
- The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
-
Immunogen
- Synthesized peptide derived from internal of Human MFNG.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- WB:1:500-1:3000,
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- Rabbit IgG in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C,-80 °C
-
Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- Manic Fringe (MFNG) (MFNG)
-
Andere Bezeichnung
- MFNG
-
Hintergrund
-
Background: Glycosyltransferase involved in the elongation of O-linked ligands to activate Notch signaling. Possesses fucose-specific beta-1,3-N-acetylglucosaminyltransferase activity.
Johnston S.H., Development 124:2245-2254(1997).
Collins J.E., Genome Biol. 5:R84.1-R84.11(2004).
Dunham I., Nature 402:489-495(1999).Aliases: 3-N-acetylglucosaminyltransferase manic fringe antibody, Beta-1 antibody, Beta-1,3-N-acetylglucosaminyltransferase manic fringe antibody, MFNG antibody, MFNG_HUMAN antibody, O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase antibody
-
UniProt
- O00587
-
Pathways
- Notch Signalweg
Target
-